32 related articles for article (PubMed ID: 8229746)
1. Effects of sex and hydration status on kappa opioid receptor-mediated diuresis in rats.
Lalji HM; Bailey CP; Husbands SM; Bailey SJ
Basic Clin Pharmacol Toxicol; 2024 Jun; 134(6):792-804. PubMed ID: 38584299
[TBL] [Abstract][Full Text] [Related]
2. Electrical stimulation of renal nerves for modulating urine glucose excretion in rats.
Jiman AA; Chhabra KH; Lewis AG; Cederna PS; Seeley RJ; Low MJ; Bruns TM
Bioelectron Med; 2018; 4():7. PubMed ID: 32232083
[TBL] [Abstract][Full Text] [Related]
3. The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies.
Dalefield ML; Scouller B; Bibi R; Kivell BM
Front Pharmacol; 2022; 13():837671. PubMed ID: 35795569
[TBL] [Abstract][Full Text] [Related]
4. Nalfurafine, a G-Protein-Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics.
Meariman JK; Sutphen JC; Gao J; Kapusta DR
Hypertension; 2022 Feb; 79(2):379-390. PubMed ID: 34852633
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and renal effects of novel nonpeptide nociceptin opioid peptide receptor agonists.
Denys IB; Gao J; Sutphen JC; Zaveri NT; Kapusta DR
Br J Pharmacol; 2022 Jan; 179(2):287-300. PubMed ID: 34705263
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox.
Dao M; François H
Front Endocrinol (Lausanne); 2021; 12():720734. PubMed ID: 34305821
[TBL] [Abstract][Full Text] [Related]
7. Kappa Opioid Agonist-Induced Diuresis: Characteristics, Mechanisms, and Beyond.
Inan S
Handb Exp Pharmacol; 2022; 271():401-417. PubMed ID: 33483878
[TBL] [Abstract][Full Text] [Related]
8. Renal responses produced by microinjection of the kappa opioid receptor agonist, U50-488H, into sites within the rat lamina terminalis.
Franklin C; Fortepiani L; Nguyen T; Rangel Y; Strong R; Gottlieb HB
Pharmacol Res Perspect; 2015 Mar; 3(2):e00117. PubMed ID: 26038693
[TBL] [Abstract][Full Text] [Related]
9. Diuretic effects of cannabinoid agonists in mice.
Chopda GR; Vemuri VK; Sharma R; Thakur GA; Makriyannis A; Paronis CA
Eur J Pharmacol; 2013 Dec; 721(1-3):64-9. PubMed ID: 24099963
[TBL] [Abstract][Full Text] [Related]
10. Opioid system and Alzheimer's disease.
Cai Z; Ratka A
Neuromolecular Med; 2012 Jun; 14(2):91-111. PubMed ID: 22527793
[TBL] [Abstract][Full Text] [Related]
11. Bremazocine: a kappa-opioid agonist with potent analgesic and other pharmacologic properties.
Dortch-Carnes J; Potter DE
CNS Drug Rev; 2005; 11(2):195-212. PubMed ID: 16007240
[TBL] [Abstract][Full Text] [Related]
12. Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys.
Ko MC; Willmont KJ; Lee H; Flory GS; Woods JH
Brain Res; 2003 Aug; 982(1):38-44. PubMed ID: 12915238
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of kappa-opioid receptor agonism on long-term methamphetamine-induced neurotoxicity in rats.
Johnson-Davis KL; Hanson GR; Keefe KA
Neurotox Res; 2003; 5(4):273-81. PubMed ID: 12835119
[TBL] [Abstract][Full Text] [Related]
14. Endogenous opiates: 1993.
Olson GA; Olson RD; Kastin AJ
Peptides; 1994; 15(8):1513-56. PubMed ID: 7700854
[TBL] [Abstract][Full Text] [Related]
15. Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.
Kapusta DR; Obih JC
J Pharmacol Exp Ther; 1993 Oct; 267(1):197-204. PubMed ID: 8229746
[TBL] [Abstract][Full Text] [Related]
16. Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats.
Kapusta DR; Jones SY; DiBona GF
J Pharmacol Exp Ther; 1989 Oct; 251(1):230-7. PubMed ID: 2552076
[TBL] [Abstract][Full Text] [Related]
17. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus.
Gottlieb HB; Varner KJ; Kenigs VA; Cabral AM; Kapusta DR
J Pharmacol Exp Ther; 2005 Feb; 312(2):678-85. PubMed ID: 15381735
[TBL] [Abstract][Full Text] [Related]
18. Central kappa opioids blunt the renal excretory responses to volume expansion by a renal nerve-dependent mechanism.
Kapusta DR; Obih JC
J Pharmacol Exp Ther; 1995 Apr; 273(1):199-205. PubMed ID: 7714767
[TBL] [Abstract][Full Text] [Related]
19. Opioid mechanisms controlling renal function.
Kapusta DR
Clin Exp Pharmacol Physiol; 1995 Dec; 22(12):891-902. PubMed ID: 8846510
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
